| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88241891 | FILING DATE | 12/26/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | GALBO, AMANDA |
L.O. ASSIGNED | N70-NOT FOUND |
PUB INFORMATION |
|||
| RUN DATE | 09/26/2020 | ||
| PUB DATE | 07/30/2019 | ||
| STATUS | 731-SECOND EXTENSION - GRANTED | ||
| STATUS DATE | 09/24/2020 | ||
| LITERAL MARK ELEMENT | INTERVENN | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | INTERVENN |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Venn Biosciences Corporation |
| ADDRESS | 800 Chesapeake Drive Redwood City, CA 94063 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 009 |
| DESCRIPTION TEXT | Computer software applications for operating research instrument and medical diagnostic devices for measuring, testing and analysis of biological molecules in the nature of proteins, nucleic acids, metabolites and biospecimens in the nature of cells, tissue, and biofluids for use in computing, studying, diagnosing or screening for diseases and studying biological molecules; Computer software applications for operating research instrument and medical diagnostic devices for measuring, testing and analysis of post-translational modifications of proteins for use in computing, studying, diagnosing or screening for diseases and studying biological molecules |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Scientific and medical research services; scientific and medical research services, namely, biomarker and target discovery services for pharmaceutical development; scientific and medical research services, namely, biomarker discovery and target discovery; providing a database in the field of bioinformatics for medical or scientific research; providing temporary use of on-line nondownloadable software applications for operating research instrument and medical diagnostic devices for measuring and testing biological molecules and biospecimens for use in computing, studying, diagnosing or screening for diseases and studying biological molecules; chemical analysis, namely, mass spectrometry services; consulting services in the field of biotechnology through the application of mass spectrometry; scientific and technological services, namely, biomarker analysis in the field of mass spectrometry; scientific and technological analyses using mass spectrometry, namely, chemical, biochemical, and biological in the nature of protein and cellular analysis; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics |
| INTERNATIONAL CLASS | 044 |
| DESCRIPTION TEXT | Testing and reporting for medical biomarker discovery and validation, target discovery and validation, therapeutics design and development, patient profiling, treatment prediction and monitoring, and medical diagnostic and prognostic purposes; medical testing for screening, diagnostic, or treatment purposes; medical diagnostic testing, monitoring, and reporting services; providing a website featuring medical information regarding disease risk factors, disease risk factor analysis, and reporting services for medical purposes |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 009 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 044 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| PSEUDO MARK | INTERVEIN |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 09/26/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 032 |
| 09/24/2020 | EX2G | S | EXTENSION 2 GRANTED | 031 |
| 09/24/2020 | EXT2 | S | EXTENSION 2 FILED | 030 |
| 09/24/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 029 |
| 09/22/2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 028 |
| 09/22/2020 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 027 |
| 09/22/2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 026 |
| 09/22/2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 025 |
| 03/06/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 024 |
| 03/04/2020 | EX1G | S | EXTENSION 1 GRANTED | 023 |
| 03/04/2020 | EXT1 | S | EXTENSION 1 FILED | 022 |
| 03/04/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 021 |
| 09/24/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 020 |
| 07/30/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 019 |
| 07/30/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 018 |
| 07/10/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 017 |
| 06/26/2019 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | 016 |
| 06/25/2019 | ALIE | A | ASSIGNED TO LIE | 015 |
| 06/17/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 014 |
| 06/17/2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 013 |
| 06/17/2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 012 |
| 06/17/2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 011 |
| 06/17/2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 010 |
| 06/13/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 009 |
| 06/12/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 008 |
| 06/12/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
| 03/21/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
| 03/21/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
| 03/21/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
| 03/19/2019 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 01/17/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 12/29/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Philip R. Zende |
| CORRESPONDENCE ADDRESS | Philip R. Zende SQUIRE PATTON BOGGS (US) LLP 275 BATTERY STREET, SUITE 2600 SAN FRANCISCO CA 94111 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Venn Biosciences Corporation |
| ADDRESS | 800 Chesapeake Drive Redwood City, CA 94063 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |